ArticlePloS one2023

Protocol of BEYOND trial: Clinical BEnefit of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in rhYthm cONtrol of atrial fibrillation in patients with diabetes mellitus.

Kyuhyun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.